US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist
  • 1.074
  • +0.024+2.27%
Trading Dec 2 14:09 ET
81.44MMarket Cap-2386P/E (TTM)

Clearside Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.67%-5.91M
-6.39%-5.68M
-8.80%-7.85M
-35.69%-18.14M
108.83%495K
1.79%-6.08M
1.91%-5.34M
-286.41%-7.22M
-24.52%-13.37M
-210.94%-5.61M
Net income from continuing operations
17.03%-7.69M
16.60%-7.59M
-26.76%-11.76M
1.40%-32.49M
49.99%-4.83M
-18.40%-9.27M
-16.55%-9.11M
-21.40%-9.28M
-8,862.50%-32.95M
-151.65%-9.66M
Operating gains losses
---364K
---1.92M
--1.5M
----
----
----
----
----
103.31%33K
----
Depreciation and amortization
368.75%75K
175.00%44K
86.67%28K
-53.79%67K
-9.09%20K
-58.97%16K
-57.89%16K
-67.39%15K
-18.54%145K
-51.11%22K
Other non cash items
-6.29%2.46M
2.01%2.34M
10.89%2.4M
185.05%9.36M
14.65%2.28M
--2.62M
--2.29M
--2.17M
--3.28M
--1.99M
Change In working capital
-165.38%-1.38M
10.35%437K
6.82%-1.08M
-93.59%720K
131.56%2M
32.38%-520K
-59.51%396K
-111.41%-1.16M
173.23%11.24M
105.78%865K
-Change in receivables
----
----
----
-102.11%-220K
----
----
----
----
195.87%10.42M
----
-Change in prepaid assets
-22.28%-1.11M
665.22%352K
368.48%443K
----
----
-73.52%-911K
121.70%46K
-101.54%-165K
----
----
-Change in payables and accrued expense
-104.26%-32K
-93.26%19K
-4.03%-1.11M
-11.53%614K
146.01%647K
339.49%752K
-80.29%282K
-55.54%-1.07M
1.91%694K
-45.32%263K
-Change in other working capital
35.18%-234K
-2.94%66K
-665.75%-413K
167.21%326K
307.46%546K
-615.71%-361K
128.22%68K
-54.09%73K
102.37%122K
102.66%134K
Cash from discontinued investing activities
Operating cash flow
2.67%-5.91M
-6.39%-5.68M
-8.80%-7.85M
-35.69%-18.14M
108.83%495K
1.79%-6.08M
1.91%-5.34M
-286.41%-7.22M
-24.52%-13.37M
-210.94%-5.61M
Investing cash flow
Cash flow from continuing investing activities
448.09%1.55M
-942.57%-11.44M
50.43%-57K
-622.36%-1.78M
-31.87%-120K
-187.10%-445K
-1.1M
-115K
-246K
-91K
Net PPE purchase and sale
88.09%-53K
61.44%-423K
50.43%-57K
-622.36%-1.78M
-31.87%-120K
-187.10%-445K
---1.1M
---115K
---246K
---91K
Net investment purchase and sale
--1.6M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
448.09%1.55M
-942.57%-11.44M
50.43%-57K
-622.36%-1.78M
-31.87%-120K
-187.10%-445K
---1.1M
---115K
---246K
---91K
Financing cash flow
Cash flow from continuing financing activities
-95.58%14K
0
4,220.18%14.34M
-98.68%414K
-144.70%-257K
-98.97%317K
450.00%22K
410.77%332K
31.75%31.33M
248.48%575K
Net common stock issuance
--0
--0
4,750.85%14.31M
194.35%1.67M
31.27%743K
--266K
--362K
--295K
-97.57%566K
18,966.67%566K
Proceeds from stock option exercised by employees
-72.55%14K
--0
-10.81%33K
-24.03%98K
--0
0.00%51K
150.00%10K
-43.08%37K
-74.15%129K
-94.64%9K
Net other financing activities
----
----
----
-104.41%-1.35M
---1M
--0
----
----
--30.64M
--0
Cash from discontinued financing activities
Financing cash flow
-95.58%14K
--0
4,220.18%14.34M
-98.68%414K
-144.70%-257K
-98.97%317K
450.00%22K
410.77%332K
31.75%31.33M
248.48%575K
Net cash flow
Beginning cash position
-47.90%18.24M
-14.64%35.36M
-40.27%28.92M
57.73%48.42M
-46.21%28.8M
19.91%35.01M
19.60%41.42M
57.73%48.42M
73.94%30.7M
110.15%53.54M
Current changes in cash
29.87%-4.35M
-166.87%-17.12M
191.94%6.44M
-210.02%-19.5M
102.30%118K
-125.48%-6.2M
-17.93%-6.41M
-277.82%-7M
35.81%17.72M
-198.16%-5.12M
End cash Position
-51.78%13.89M
-47.90%18.24M
-14.64%35.36M
-40.27%28.92M
-40.27%28.92M
-46.21%28.8M
19.91%35.01M
19.60%41.42M
57.73%48.42M
57.73%48.42M
Free cash flow
8.50%-5.97M
5.17%-6.1M
-7.87%-7.91M
-46.29%-19.91M
106.58%375K
-2.82%-6.52M
-18.24%-6.44M
-289.38%-7.33M
-26.81%-13.61M
-212.74%-5.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.67%-5.91M-6.39%-5.68M-8.80%-7.85M-35.69%-18.14M108.83%495K1.79%-6.08M1.91%-5.34M-286.41%-7.22M-24.52%-13.37M-210.94%-5.61M
Net income from continuing operations 17.03%-7.69M16.60%-7.59M-26.76%-11.76M1.40%-32.49M49.99%-4.83M-18.40%-9.27M-16.55%-9.11M-21.40%-9.28M-8,862.50%-32.95M-151.65%-9.66M
Operating gains losses ---364K---1.92M--1.5M--------------------103.31%33K----
Depreciation and amortization 368.75%75K175.00%44K86.67%28K-53.79%67K-9.09%20K-58.97%16K-57.89%16K-67.39%15K-18.54%145K-51.11%22K
Other non cash items -6.29%2.46M2.01%2.34M10.89%2.4M185.05%9.36M14.65%2.28M--2.62M--2.29M--2.17M--3.28M--1.99M
Change In working capital -165.38%-1.38M10.35%437K6.82%-1.08M-93.59%720K131.56%2M32.38%-520K-59.51%396K-111.41%-1.16M173.23%11.24M105.78%865K
-Change in receivables -------------102.11%-220K----------------195.87%10.42M----
-Change in prepaid assets -22.28%-1.11M665.22%352K368.48%443K---------73.52%-911K121.70%46K-101.54%-165K--------
-Change in payables and accrued expense -104.26%-32K-93.26%19K-4.03%-1.11M-11.53%614K146.01%647K339.49%752K-80.29%282K-55.54%-1.07M1.91%694K-45.32%263K
-Change in other working capital 35.18%-234K-2.94%66K-665.75%-413K167.21%326K307.46%546K-615.71%-361K128.22%68K-54.09%73K102.37%122K102.66%134K
Cash from discontinued investing activities
Operating cash flow 2.67%-5.91M-6.39%-5.68M-8.80%-7.85M-35.69%-18.14M108.83%495K1.79%-6.08M1.91%-5.34M-286.41%-7.22M-24.52%-13.37M-210.94%-5.61M
Investing cash flow
Cash flow from continuing investing activities 448.09%1.55M-942.57%-11.44M50.43%-57K-622.36%-1.78M-31.87%-120K-187.10%-445K-1.1M-115K-246K-91K
Net PPE purchase and sale 88.09%-53K61.44%-423K50.43%-57K-622.36%-1.78M-31.87%-120K-187.10%-445K---1.1M---115K---246K---91K
Net investment purchase and sale --1.6M------------------0----------------
Cash from discontinued investing activities
Investing cash flow 448.09%1.55M-942.57%-11.44M50.43%-57K-622.36%-1.78M-31.87%-120K-187.10%-445K---1.1M---115K---246K---91K
Financing cash flow
Cash flow from continuing financing activities -95.58%14K04,220.18%14.34M-98.68%414K-144.70%-257K-98.97%317K450.00%22K410.77%332K31.75%31.33M248.48%575K
Net common stock issuance --0--04,750.85%14.31M194.35%1.67M31.27%743K--266K--362K--295K-97.57%566K18,966.67%566K
Proceeds from stock option exercised by employees -72.55%14K--0-10.81%33K-24.03%98K--00.00%51K150.00%10K-43.08%37K-74.15%129K-94.64%9K
Net other financing activities -------------104.41%-1.35M---1M--0----------30.64M--0
Cash from discontinued financing activities
Financing cash flow -95.58%14K--04,220.18%14.34M-98.68%414K-144.70%-257K-98.97%317K450.00%22K410.77%332K31.75%31.33M248.48%575K
Net cash flow
Beginning cash position -47.90%18.24M-14.64%35.36M-40.27%28.92M57.73%48.42M-46.21%28.8M19.91%35.01M19.60%41.42M57.73%48.42M73.94%30.7M110.15%53.54M
Current changes in cash 29.87%-4.35M-166.87%-17.12M191.94%6.44M-210.02%-19.5M102.30%118K-125.48%-6.2M-17.93%-6.41M-277.82%-7M35.81%17.72M-198.16%-5.12M
End cash Position -51.78%13.89M-47.90%18.24M-14.64%35.36M-40.27%28.92M-40.27%28.92M-46.21%28.8M19.91%35.01M19.60%41.42M57.73%48.42M57.73%48.42M
Free cash flow 8.50%-5.97M5.17%-6.1M-7.87%-7.91M-46.29%-19.91M106.58%375K-2.82%-6.52M-18.24%-6.44M-289.38%-7.33M-26.81%-13.61M-212.74%-5.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data